FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 125 filers reported holding FATE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,488,000 | +350.9% | 25,100 | +560.5% | 0.00% | – |
| Q2 2021 | $330,000 | -94.8% | 3,800 | -94.5% | 0.00% | -100.0% |
| Q4 2020 | $6,332,000 | +363.9% | 69,636 | +103.9% | 0.01% | +350.0% |
| Q3 2020 | $1,365,000 | +118.8% | 34,159 | +7.1% | 0.00% | +100.0% |
| Q4 2019 | $624,000 | +84.1% | 31,900 | +65.3% | 0.00% | 0.0% |
| Q1 2019 | $339,000 | +145.7% | 19,300 | +79.2% | 0.00% | – |
| Q4 2018 | $138,000 | – | 10,770 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |